Wide Ranks

HLVX

HilleVax, Inc.

1.92

Top Statistics
Market Cap 95 M Forward PE -1.19 Revenue Growth 0.00 %
Current Ratio 14.25 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.5350 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 189 M Total Cash Per Share 3.92 Total Debt 24 M
Total Debt To Equity 13.55 Current Ratio 14.25 Book Value Per Share 3.82
All Measures
Short Ratio 885.00 % Message Board Id finmb_1680788968 Shares Short Prior Month 1 M
Return On Equity -0.6224 City Boston Uuid ad85351d-ccca-3533-9e30-baa1f712efa8
Previous Close 1.91 First Trade Date Epoch Utc 1 B Book Value 3.82
Beta 0.7730 Total Debt 24 M Volume 122037
Price To Book 0.5025 Fifty Two Week Low 1.55 Total Cash Per Share 3.92
Shares Short Previous Month Date 1 B Target Median Price 2.50 Max Age 86400
Sand P52 Week Change 0.3133 Target Mean Price 3.00 Net Income To Common -150280000
Short Percent Of Float 0.1508 Implied Shares Outstanding 49 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 134530 Average Volume10days 134530
Total Cash 189 M Next Fiscal Year End 1 B Held Percent Insiders 0.1711
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 1.91 Target Low Price 2.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.84 Open 1.90 Free Cashflow -85403872
State MA Dividend Yield 0.00 % Return On Assets -0.2890
Time Zone Short Name EST Trailing Eps -3.09 Day Low 1.90
Address1 321 Harrison Avenue Shares Outstanding 49 M Price Hint 4
Target High Price 5.00 Website https://www.hillevax.com 52 Week Change -0.8600
Average Volume 186223 Forward Eps -1.87 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 1368.20 % Is_sp_500 False
Regular Market Day High 1.97 Profit Margins 0.00 % Debt To Equity 13.55
Fifty Two Week High 20.22 Day High 1.97 Shares Short 1 M
Regular Market Open 1.90 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0244 Operating Cashflow -112209000
Currency USD Time Zone Full Name America/New_York Market Cap 95 M
Is_nasdaq_100 False Zip 02118 Quote Type EQUITY
Industry Biotechnology Long Name HilleVax, Inc. Regular Market Day Low 1.90
Held Percent Institutions 0.7529 Current Price 1.92 Address2 5th floor
Enterprise To Ebitda 0.5350 Financial Currency USD Current Ratio 14.25
Industry Disp Biotechnology Number Of Analyst Opinions 4 Country United States
Float Shares 24 M Two Hundred Day Average 8.18 Enterprise Value -71727040
Forward PE -1.19 Regular Market Volume 122037 Ebitda -134042000
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States.

It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.

The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021.

HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.